It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile

-or-

call (888) 352-RUSH for help arranging an appointment

Marvin A. Rossi, MD, PhD

Specialty:
  • Neurology
Board Certification:
  • Neurology
Faculty Rank: Assistant Professor
Medical or Graduate Education: Rush Medical College
Residency: University of Chicago Medical Center - Neurology
Fellowship: University of Chicago Medical Center - Clinical Neurophysiology
  Rush University Medical Center - Advanced Epilepsy
Clinical Expertise:
  • Cortical mapping
  • Developmental delay
  • Electroencephalogram (EEG)
  • Epilepsy
  • Epilepsy, treatment-resistant
  • Evoked potential testing
  • Landau-Kleffner syndrome
  • Language delay
  • Methohexital suppression testing
  • Pseudoseizures
  • Wada test
Research Interests:
  • Localization of the ictal onset zone for epilepsy surgery
  • Neurochemical markers of synaptic plasticity
Languages Spoken:
  • English
Google Map
  • University Neurologists
  • Professional Building
  • 1725 W. Harrison St.
  • Suite 885
  • Chicago, IL  60612
  • Phone: (312) 942-5936
  • Fax: (312) 942-2238
  • View Larger MapDriving Directions

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Improving patient-centered care coordination for children with epilepsy: version 2.0 upgrade required.
    Rossi MA
    Epilepsy Curr
    2014 May
    14(3):145-6.
  2. Chronic unlimited recording electrocorticography-guided resective epilepsy surgery: technology-enabled enhanced fidelity in seizure focus localization with improved surgical efficacy.
    DiLorenzo DJ, Mangubat EZ, Rossi MA, Byrne RW
    J. Neurosurg.
    2014 Jun
    120(6):1402-14.
  3. Juvenile myoclonic epilepsy: when will it end.
    Rossi MA
    Epilepsy Curr
    2013 May
    13(3):148-9.
  4. Chronic epilepsy due to low grade temporal lobe tumors and due to hippocampal sclerosis: Do they differ in post-surgical outcome?
    Vannemreddy PS, Kanner AM, Smith MC, Rossi M, Wallace D, Vannemreddy SN, Byrne RW
    J. Neurooncol.
    2013 Aug 17
  5. Tailored temporal lobectomy for medically intractable epilepsy: evaluation of pathology and predictors of outcome.
    Falowski SM, Wallace D, Kanner A, Smith M, Rossi M, Balabanov A, Ouyang B, Byrne RW.
    Neurosurgery. 2012
    2012 Sep
    71(3):703-9; discussion 709. doi: 10.1227/NEU.0b013e318262161d.
  6. Targeting anti-epileptic drug therapy without collateral damage: nanocarrier-based drug delivery.
    Rossi MA.
    Epilepsy Curr. 2012
    2012 Sep
    12(5):199-200. doi: 10.5698/1535-7511-12.5.199. No abstract available.
  7. Deep white matter track record of functional integrity in childhood absence epilepsy.
    Rossi MA.
    Epilepsy Curr. 2012
    2012 Nov
    12(6):234-5. doi: 10.5698/1535-7511-12.6.234. No abstract available.
  8. Predicting white matter targets for direct neurostimulation therapy.
    Rossi MA, Stebbins G, Murphy C, Greene D, Brinker S, Sarcu D, Tenharmsel A, Stoub T, Stein MA, Hoeppner TJ, Byrne RW, Moseley ME, Bammer RA, Bild S, Dennis J, Arnett N, Balabanov A, Bergen D, Kanner AM, Smith MC.
    Epilepsy Res. 2010
    2010 Oct
    91(2-3):176-86. doi: 10.1016/j.eplepsyres.2010.07.010. Epub 2010 Aug 21.
  9. Epilepsy surgery and vagal nerve stimulation: what all neurologists should know.
    Balabanov A, Rossi MA.
    Semin Neurol. 2008
    2008 Jul
    28(3):355-63. doi: 10.1055/s-2008-1079340. Epub 2008 Jul 24. Review.